후지제약 주식회사: 손익 계산서 (TTM)

후지제약 주식회사
DE ˙ DB ˙ JP3816200004
€11.40 ↓ -0.20 (-1.72%)
2026-06-04
주가
손익 계산서 (TTM)

후지제약 주식회사 손익 계산서(Income Statement)에는 일정 기간 동안의 소득 및 지출 변화가 표시됩니다. 손익 계산서 데이터에는 판매액(Sales), 매출액(Revenue), 총이익(Gross Profit), 연구개발(R&D), 판매 및 관리비(SG&A: Selling, General and Administrative Expense), 영업이익(Operating Income), 소득세 비용, 이자 비용, 비영업이익, 주당이익(EPS: Earnings per Share) 및 발행 주식수로 구성됩니다.

모든 수치는 지분 단위당 1,000,000 제외의 곱입니다.123456

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
수익 34,392 33,990 34,141 34,439 34,962 35,426 35,976 36,925 38,438 40,889 41,639 43,052 44,562 46,138 48,392 48,845 49,937 51,677 54,574 57,298
변화 (%) -1.17 0.44 0.87 1.52 1.33 1.55 2.64 4.10 6.38 1.83 3.39 3.51 3.54 4.89 0.94 2.24 3.48 5.61 4.99
수익의 % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
매출원가 19,370 19,239 19,420 19,676 20,186 20,867 21,388 22,418 23,505 24,374 25,605 25,927 27,060 28,294 28,796 29,345 29,854 30,914 32,297 34,091
변화 (%) -0.68 0.94 1.32 2.59 3.37 2.50 4.82 4.85 3.70 5.05 1.26 4.37 4.56 1.77 1.91 1.73 3.55 4.47 5.55
수익의 % 56.32 56.60 56.88 57.13 57.74 58.90 59.45 60.71 61.15 59.61 61.49 60.22 60.72 61.32 59.51 60.08 59.78 59.82 59.18 59.50
총 영업 이익 15,022 14,751 14,721 14,763 14,776 14,559 14,588 14,507 14,933 16,515 16,034 17,125 17,502 17,844 19,596 19,500 20,083 20,763 22,277 23,207
변화 (%) -1.80 -0.20 0.29 0.09 -1.47 0.20 -0.56 2.94 10.59 -2.91 6.80 2.20 1.95 9.82 -0.49 2.99 3.39 7.29 4.17
수익의 % 43.68 43.40 43.12 42.87 42.26 41.10 40.55 39.29 38.85 40.39 38.51 39.78 39.28 38.68 40.49 39.92 40.22 40.18 40.82 40.50
판매관리비 6,821 8,340 8,446 8,326 8,353 7,355 7,756 8,191 8,939 8,331 9,180 9,321 9,504 9,231 9,590 10,026 10,318 10,957 10,934 11,308
변화 (%) 22.27 1.27 -1.42 0.32 -11.95 5.45 5.61 9.13 -6.80 10.19 1.54 1.96 -2.87 3.89 4.55 2.91 6.19 -0.21 3.42
수익의 % 19.83 24.54 24.74 24.18 23.89 20.76 21.56 22.18 23.26 20.37 22.05 21.65 21.33 20.01 19.82 20.53 20.66 21.20 20.04 19.74
연구개발 3,060 2,446 2,446 2,446 2,446 2,485 2,485 2,485 2,485 3,184 3,184 3,184 3,184 3,401 3,401 3,401 3,401 3,344 3,344 3,344
변화 (%) -20.07 0.00 0.00 0.00 1.59 0.00 0.00 0.00 28.13 0.00 0.00 0.00 6.82 0.00 0.00 0.00 -1.68 0.00 0.00
수익의 % 8.90 7.20 7.16 7.10 7.00 7.01 6.91 6.73 6.46 7.79 7.65 7.40 7.15 7.37 7.03 6.96 6.81 6.47 6.13 5.84
운영 비용 29,875 30,641 30,928 31,064 31,601 31,648 32,570 34,035 35,870 37,030 39,110 39,573 40,889 42,257 43,118 44,103 44,904 46,687 48,047 50,215
변화 (%) 2.56 0.94 0.44 1.73 0.15 2.91 4.50 5.39 3.23 5.62 1.18 3.33 3.35 2.04 2.28 1.82 3.97 2.91 4.51
수익의 % 86.87 90.15 90.59 90.20 90.39 89.34 90.53 92.17 93.32 90.56 93.93 91.92 91.76 91.59 89.10 90.29 89.92 90.34 88.04 87.64
영업 이익 4,517 3,349 3,213 3,375 3,361 3,778 3,406 2,890 2,568 3,859 2,529 3,479 3,673 3,881 5,274 4,742 5,033 4,990 6,527 7,083
변화 (%) -25.86 -4.06 5.04 -0.41 12.41 -9.85 -15.15 -11.14 50.27 -34.46 37.56 5.58 5.66 35.89 -10.09 6.14 -0.85 30.80 8.52
수익의 % 13.13 9.85 9.41 9.80 9.61 10.66 9.47 7.83 6.68 9.44 6.07 8.08 8.24 8.41 10.90 9.71 10.08 9.66 11.96 12.36
이자 비용 -37 -53 -68 -79 -82 -77 -92 -99 -113 -121 -123 -138 -165 -196 -233 -255 -296 -330 -338 -379
변화 (%) 43.24 28.30 16.18 3.80 -6.10 19.48 7.61 14.14 7.08 1.65 12.20 19.57 18.79 18.88 9.44 16.08 11.49 2.42 12.13
수익의 % -0.11 -0.16 -0.20 -0.23 -0.23 -0.22 -0.26 -0.27 -0.29 -0.30 -0.30 -0.32 -0.37 -0.42 -0.48 -0.52 -0.59 -0.64 -0.62 -0.66
당기순이익 3,161 2,432 2,222 2,245 2,433 2,696 2,692 2,634 2,036 3,435 5,060 5,920 6,363 6,146 4,398 3,176 3,066 3,000 2,333 2,426
변화 (%) -23.06 -8.63 1.04 8.37 10.81 -0.15 -2.15 -22.70 68.71 47.31 17.00 7.48 -3.41 -28.44 -27.79 -3.46 -2.15 -22.23 3.99
수익의 % 9.19 7.16 6.51 6.52 6.96 7.61 7.48 7.13 5.30 8.40 12.15 13.75 14.28 13.32 9.09 6.50 6.14 5.81 4.27 4.23

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
JP:4554 JP¥2,178.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista